News
12d
GlobalData on MSNFDA clears eGenesis’ genetically engineered porcine liver for Phase I trialThe company’s porcine liver is for use with partner OrganOx’s extracorporeal liver cross-circulation (ELC) system in patients ...
CAMBRIDGE, Mass. & OXFORD, England, April 15, 2025--eGenesis and OrganOx Announce U.S. FDA Clearance of IND Application for ...
A team led by Children's Hospital Los Angeles has become the first in the world to demonstrate the possibility of using ...
A patient with end-stage kidney disease successfully received a genetically engineered porcine kidney and was released from ...
OXFORD, England--(BUSINESS WIRE)--eGenesis, a biotechnology company developing human-compatible engineered organs to treat patients suffering from organ failure, and OrganOx Ltd., a leading organ ...
eGenesis, a biotechnology company developing human-compatible engineered organs to treat patients suffering from organ failure, and OrganOx Ltd., a leading organ medical technology company ...
U.S. researchers are about to test if livers from gene-edited pigs could treat people with sudden liver failure — not with a transplant but temporarily attached outside the body ...
12d
HealthDay on MSNNew Trial Will Test Gene-Edited Pig Liver for Sudden Liver Failure PatientsKey Takeaways A new trial will beging testing pig livers to support people with sudden liver failureThe pig liver won't be ...
GM unveiled the 2026 Cadillac Optiq V. The new option is part of GM's plans to offer all-electric powertrain options on its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results